- Home
- JAZZ vs HMY Comparison
JAZZ vs HMY Comparison
Compare JAZZ & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JAZZ | HMY |
|---|---|---|
| Founded | 2003 | 1950 |
| Country | Ireland | South Africa |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 12.4B |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | JAZZ | HMY |
|---|---|---|
| Price | $169.80 | $21.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 2 |
| Target Price | ★ $199.20 | $16.00 |
| AVG Volume (30 Days) | 1.1M | ★ 4.1M |
| Earning Date | 11-05-2025 | 02-04-2016 |
| Dividend Yield | N/A | ★ 0.81% |
| EPS Growth | N/A | ★ 67.74 |
| EPS | N/A | ★ 1.29 |
| Revenue | $4,157,832,999.00 | ★ $4,161,584,110.00 |
| Revenue This Year | $6.00 | $39.51 |
| Revenue Next Year | $6.84 | $14.06 |
| P/E Ratio | ★ N/A | $15.72 |
| Revenue Growth | 4.14 | ★ 20.39 |
| 52 Week Low | $95.49 | $7.97 |
| 52 Week High | $182.99 | $22.25 |
Technical Indicators
Market Signals| Indicator | JAZZ | HMY |
|---|---|---|
| Relative Strength Index (RSI) | 58.58 | 67.67 |
| Support Level | $164.39 | $20.10 |
| Resistance Level | $172.00 | $20.80 |
| Average True Range (ATR) | 4.28 | 0.78 |
| MACD | -1.26 | 0.10 |
| Stochastic Oscillator | 78.09 | 91.72 |
Price Performance
Historical ComparisonAbout JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.